Tag: Hollister Biosciences - Psychedelic Alpha

Access exclusive insights, data and interviews with Pα+: learn more and subscribe today.

Read more about the article Hollister Biosciences Inc. Provides Update on Q3 2020 Performance

Hollister Biosciences Inc. Provides Update on Q3 2020 Performance

Post published:October 27, 2020
Post category:Press Release

Read more about the article Hollister Biosciences 100% Owned Subsidiary Venom Extracts Achieves Initial $30 Million Revenue Milestone

Hollister Biosciences 100% Owned Subsidiary Venom Extracts Achieves Initial $30 Million Revenue Milestone

Post published:October 6, 2020
Post category:Press Release

Read more about the article Hollister Biosciences Retains Renmark Financial Communications Inc.

Hollister Biosciences Retains Renmark Financial Communications Inc.

Post published:September 11, 2020
Post category:Press Release

Read more about the article Hollister Biosciences Inc. Reports Second Quarter 2020 Results

Hollister Biosciences Inc. Reports Second Quarter 2020 Results

Post published:August 24, 2020
Post category:Financials Press Release

Read more about the article Hollister Biosciences Inc. Closes $1.5 Million Private Placement Financing

Hollister Biosciences Inc. Closes $1.5 Million Private Placement Financing

Post published:August 11, 2020
Post category:Press Release

Read more about the article Hollister Biosciences Inc. Announces Private Placement Financing of Up to $1.5 Million

Hollister Biosciences Inc. Announces Private Placement Financing of Up to $1.5 Million

Post published:July 2, 2020
Post category:Press Release Private Financing

Read more about the article Hollister Bioscience’s 100% Owned Subsidiary Venom Extracts Generates Record Monthly Revenue in May 2020

Hollister Bioscience’s 100% Owned Subsidiary Venom Extracts Generates Record Monthly Revenue in May 2020

Post published:June 11, 2020
Post category:Press Release

Read more about the article Hollister Biosciences Inc. Subsidiary AlphaMind Brands Inc. Plans to Launch Initial Medicinal Mushroom Based Product Line

Hollister Biosciences Inc. Subsidiary AlphaMind Brands Inc. Plans to Launch Initial Medicinal Mushroom Based Product Line

Post published:June 4, 2020
Post category:Press Release

Read more about the article Hollister Biosciences Inc. CEO Provides Corporate Update

Hollister Biosciences Inc. CEO Provides Corporate Update

Post published:May 14, 2020
Post category:Press Release

Read more about the article Cannabis Company Hollister Biosciences Signs Letter of Intent to Acquire Mushroom-based Health Company Alphamind Brands

Cannabis Company Hollister Biosciences Signs Letter of Intent to Acquire Mushroom-based Health Company Alphamind Brands

Post published:March 13, 2020
Post category:News

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.